Psychosexual well-being in women using oral contraceptives containing drospirenone

Rossella E. Nappi, Francesca Albani, Silvia Tonani, Valentine Santamaria, Carla Pisani, Erica Terreno, Eihs Martini, Franco Polatti

Research output: Contribution to journalArticlepeer-review


Considerable advances have been made in hormonal contraception in recent years, geared at maximizing compliance and minimizing discontinuation. In oral contraceptive (OC) formulations, the estrogenic component, generally ethinyl estradiol (EE), has been reduced significantly and newer progestins like dienogest and drospirenone (DRSP), compounds with different molecular structures, have been introduced; in addition, new regimens (extended, flexible, 24/4 formats instead of the standard 21/7 format) and Innovative delivery systems (vaginal rings, transdermal patches, subcutaneous implants and intrauterine devices) are available. The multitude of choices allows hormonal contraception to be tailored to the individual woman in order to obtain non-contraceptive benefits, without significant side effects, and also a favorable risk/benefit profile for her general and reproductive health. Over the past few years, new OC formulations combining DRSP (3 mg), a unique progestin with both antimineralocorticold and antiandrogenic activities, with estrogen (30 mcg or 20 mcg EE), in two regimens (24/4 and 21/7) of active pills in a 28-day cycle, have shown positive effects on water retention-related weight gain and physical, emotional and psychosexual well-being. It seems likely that the use of a low-dose, well-balanced OC and the shorter 4-day hormone-free interval may minimize the side effects that can Impair quality of life and thus increase women's compliance with hormonal contraception therapy.

Original languageEnglish
Pages (from-to)71-75
Number of pages5
JournalFunctional Neurology
Issue number2
Publication statusPublished - 2009


  • 21/7 regimen
  • 24/4 regimen
  • Drospirenone
  • Oral contraceptives
  • Premenstrual disorders
  • Sexual function

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)


Dive into the research topics of 'Psychosexual well-being in women using oral contraceptives containing drospirenone'. Together they form a unique fingerprint.

Cite this